Place of normovolemic hemodilution in oncologic cervicofacial and ENT surgery. [Article in French]
Boussofara M, Damak R, Bracco D, Ravussin P
Ann Fr Anesth Reanim 2002;21(4):271-275.
NATA Rating :
Review by : Van der Linden P
This prospective study did not demonstrate a beneficial effect of acute normovolemic hemodilution (ANH) in patients undergoing cervicofacial and ENT surgery. However, it does not possess the statistical power to demonstrate such a potential beneficial effect.
In addition, ANH was not performed in the way it can be associated with a reduction in allogeneic blood exposure: post ANH target hemoglobin too high (10 g/dL) and blood volume collected limited to 1500 mL.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.